Global Atrial Fibrillation Devices Market to Reach $15.9 Billion by 2030

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Read the full report: https://www.reportlinker.com/p05961346/?utm_source=PRN

Global Atrial Fibrillation Devices Market to Reach $15.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Atrial Fibrillation Devices estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$15.9 Billion by 2030, growing at a CAGR of 12.3% over the analysis period 2022-2030. EP Ablation Catheters, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the EP Diagnostic Catheters segment is readjusted to a revised 11.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 17.2% CAGR

The Atrial Fibrillation Devices market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 10.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.4 Billion by the year 2030.

Select Competitors (Total 34 Featured)

- Abbott Laboratories, Inc.

- AtriCure, Inc.

- Biotronik SE & Co. KG

- Boston Scientific Corporation

- CardioFocus, Inc.

- Johnson & Johnson

- Koninklijke Philips NV

- Medtronic PLC

- MicroPort Scientific Corporation

- OSYPKA AG

Read the full report: https://www.reportlinker.com/p05961346/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Atrial Fibrillation Devices - Global Key Competitors Percentage

Market Share in 2022 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Atrial Fibrillation Devices

by Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Atrial Fibrillation

Devices by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa Markets for Years 2012,

2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for EP

Ablation Catheters by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for EP Ablation Catheters by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 6: World 18-Year Perspective for EP Ablation Catheters by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for EP

Diagnostic Catheters by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for EP Diagnostic Catheters by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 9: World 18-Year Perspective for EP Diagnostic Catheters

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for EP

Mapping & Recording Systems by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for EP Mapping & Recording

Systems by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 12: World 18-Year Perspective for EP Mapping & Recording

Systems by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2012, 2023 &

2030

Table 13: World Recent Past, Current & Future Analysis for

Cardiac Monitors by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Cardiac Monitors by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 15: World 18-Year Perspective for Cardiac Monitors by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for

Access Devices by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Access Devices by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 18: World 18-Year Perspective for Access Devices by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for LAA

Closure by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for LAA Closure by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 21: World 18-Year Perspective for LAA Closure by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for

Hospitals by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 24: World 18-Year Perspective for Hospitals by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for

Electrophysiology Labs by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Electrophysiology Labs by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 27: World 18-Year Perspective for Electrophysiology Labs

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for

Diagnostics by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Diagnostics by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 30: World 18-Year Perspective for Diagnostics by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for EP

Ablation by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for EP Ablation by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 33: World 18-Year Perspective for EP Ablation by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for

Surgical by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Surgical by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 36: World 18-Year Perspective for Surgical by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for

Other Types by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 38: World Historic Review for Other Types by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 39: World 18-Year Perspective for Other Types by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 40: World Recent Past, Current & Future Analysis for

Ambulatory Surgery Centers by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 41: World Historic Review for Ambulatory Surgery Centers

by Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 42: World 18-Year Perspective for Ambulatory Surgery

Centers by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2012, 2023 &

2030

Table 43: World Atrial Fibrillation Devices Market Analysis of

Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in the United States for 2023

(E)

Table 44: USA Recent Past, Current & Future Analysis for Atrial

Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 45: USA Historic Review for Atrial Fibrillation Devices

by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP

Mapping & Recording Systems, Cardiac Monitors, Access Devices,

LAA Closure and Other Types Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 46: USA 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 47: USA Recent Past, Current & Future Analysis for Atrial

Fibrillation Devices by End-Use - Hospitals, Electrophysiology

Labs and Ambulatory Surgery Centers - Independent Analysis of

Annual Sales in US$ Million for the Years 2022 through 2030 and

% CAGR

Table 48: USA Historic Review for Atrial Fibrillation Devices

by End-Use - Hospitals, Electrophysiology Labs and Ambulatory

Surgery Centers Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2012 through 2021 and % CAGR

Table 49: USA 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 50: USA Recent Past, Current & Future Analysis for Atrial

Fibrillation Devices by Application - Diagnostics, EP Ablation

and Surgical - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 51: USA Historic Review for Atrial Fibrillation Devices

by Application - Diagnostics, EP Ablation and Surgical Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 52: USA 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

CANADA

Table 53: Canada Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 54: Canada Historic Review for Atrial Fibrillation

Devices by Type - EP Ablation Catheters, EP Diagnostic

Catheters, EP Mapping & Recording Systems, Cardiac Monitors,

Access Devices, LAA Closure and Other Types Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 55: Canada 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 56: Canada Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for Atrial Fibrillation

Devices by End-Use - Hospitals, Electrophysiology Labs and

Ambulatory Surgery Centers Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 58: Canada 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 59: Canada Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 60: Canada Historic Review for Atrial Fibrillation

Devices by Application - Diagnostics, EP Ablation and Surgical

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 61: Canada 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

JAPAN

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in Japan for 2023 (E)

Table 62: Japan Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 63: Japan Historic Review for Atrial Fibrillation Devices

by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP

Mapping & Recording Systems, Cardiac Monitors, Access Devices,

LAA Closure and Other Types Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 64: Japan 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 65: Japan Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for Atrial Fibrillation Devices

by End-Use - Hospitals, Electrophysiology Labs and Ambulatory

Surgery Centers Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2012 through 2021 and % CAGR

Table 67: Japan 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 68: Japan Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Japan Historic Review for Atrial Fibrillation Devices

by Application - Diagnostics, EP Ablation and Surgical Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 70: Japan 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

CHINA

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in China for 2023 (E)

Table 71: China Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 72: China Historic Review for Atrial Fibrillation Devices

by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP

Mapping & Recording Systems, Cardiac Monitors, Access Devices,

LAA Closure and Other Types Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 73: China 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 74: China Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 75: China Historic Review for Atrial Fibrillation Devices

by End-Use - Hospitals, Electrophysiology Labs and Ambulatory

Surgery Centers Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2012 through 2021 and % CAGR

Table 76: China 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 77: China Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 78: China Historic Review for Atrial Fibrillation Devices

by Application - Diagnostics, EP Ablation and Surgical Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 79: China 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

EUROPE

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in Europe for 2023 (E)

Table 80: Europe Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Geographic Region - France,

Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Atrial Fibrillation

Devices by Geographic Region - France, Germany, Italy, UK,

Spain, Russia and Rest of Europe Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 82: Europe 18-Year Perspective for Atrial Fibrillation

Devices by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, UK, Spain, Russia and Rest of

Europe Markets for Years 2012, 2023 & 2030

Table 83: Europe Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 84: Europe Historic Review for Atrial Fibrillation

Devices by Type - EP Ablation Catheters, EP Diagnostic

Catheters, EP Mapping & Recording Systems, Cardiac Monitors,

Access Devices, LAA Closure and Other Types Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 85: Europe 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 87: Europe Historic Review for Atrial Fibrillation

Devices by End-Use - Hospitals, Electrophysiology Labs and

Ambulatory Surgery Centers Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 88: Europe 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 89: Europe Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 90: Europe Historic Review for Atrial Fibrillation

Devices by Application - Diagnostics, EP Ablation and Surgical

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 91: Europe 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

FRANCE

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in France for 2023 (E)

Table 92: France Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 93: France Historic Review for Atrial Fibrillation

Devices by Type - EP Ablation Catheters, EP Diagnostic

Catheters, EP Mapping & Recording Systems, Cardiac Monitors,

Access Devices, LAA Closure and Other Types Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 94: France 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 95: France Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 96: France Historic Review for Atrial Fibrillation

Devices by End-Use - Hospitals, Electrophysiology Labs and

Ambulatory Surgery Centers Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 97: France 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 98: France Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: France Historic Review for Atrial Fibrillation

Devices by Application - Diagnostics, EP Ablation and Surgical

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 100: France 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

GERMANY

Atrial Fibrillation Devices Market Presence - Strong/Active/

Niche/Trivial - Key Competitors in Germany for 2023 (E)

Table 101: Germany Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 102: Germany Historic Review for Atrial Fibrillation

Devices by Type - EP Ablation Catheters, EP Diagnostic

Catheters, EP Mapping & Recording Systems, Cardiac Monitors,

Access Devices, LAA Closure and Other Types Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 103: Germany 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 104: Germany Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 105: Germany Historic Review for Atrial Fibrillation

Devices by End-Use - Hospitals, Electrophysiology Labs and

Ambulatory Surgery Centers Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 106: Germany 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 107: Germany Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: Germany Historic Review for Atrial Fibrillation

Devices by Application - Diagnostics, EP Ablation and Surgical

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 109: Germany 18-Year Perspective for Atrial Fibrillation

Devices by Application - Percentage Breakdown of Value Sales

for Diagnostics, EP Ablation and Surgical for the Years 2012,

2023 & 2030

ITALY

Table 110: Italy Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP

Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac

Monitors, Access Devices, LAA Closure and Other Types -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 111: Italy Historic Review for Atrial Fibrillation

Devices by Type - EP Ablation Catheters, EP Diagnostic

Catheters, EP Mapping & Recording Systems, Cardiac Monitors,

Access Devices, LAA Closure and Other Types Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 112: Italy 18-Year Perspective for Atrial Fibrillation

Devices by Type - Percentage Breakdown of Value Sales for EP

Ablation Catheters, EP Diagnostic Catheters, EP Mapping &

Recording Systems, Cardiac Monitors, Access Devices, LAA

Closure and Other Types for the Years 2012, 2023 & 2030

Table 113: Italy Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by End-Use - Hospitals,

Electrophysiology Labs and Ambulatory Surgery Centers -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 114: Italy Historic Review for Atrial Fibrillation

Devices by End-Use - Hospitals, Electrophysiology Labs and

Ambulatory Surgery Centers Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 115: Italy 18-Year Perspective for Atrial Fibrillation

Devices by End-Use - Percentage Breakdown of Value Sales for

Hospitals, Electrophysiology Labs and Ambulatory Surgery

Centers for the Years 2012, 2023 & 2030

Table 116: Italy Recent Past, Current & Future Analysis for

Atrial Fibrillation Devices by Application - Diagnostics, EP

Ablation and Surgical - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 117: Italy Historic Review for Atrial Fibrillation

Devices by Application - Diagnostics, EP Ablation and Surgical

Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p05961346/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: [email protected]

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker